Marinus Pharmaceuticals, Inc.
MRNS · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$141,405 | -$19,816 | -$98,776 | -$67,475 |
| Dep. & Amort. | $551 | $418 | $355 | $334 |
| Deferred Tax | $0 | $0 | -$687 | $3 |
| Stock-Based Comp. | $15,563 | $14,890 | $13,867 | $7,642 |
| Change in WC | $2,169 | -$6,092 | $28,699 | -$2,042 |
| Other Non-Cash | $5,121 | -$102,286 | $1,065 | $626 |
| Operating Cash Flow | -$118,001 | -$112,886 | -$55,477 | -$60,912 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$119 | -$1,774 | -$2,889 | $0 |
| Net Acquisitions | $0 | $171 | $0 | $0 |
| Inv. Purchases | -$51,995 | -$171 | $0 | -$8,931 |
| Inv. Sales/Matur. | $23,500 | $107,375 | $1,474 | $8,193 |
| Other Inv. Act. | $9 | $171 | $1,474 | -$738 |
| Investing Cash Flow | -$28,605 | $105,772 | -$1,415 | -$738 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $58,509 | $40,259 | $0 |
| Stock Issued | $25,823 | $64,477 | $1,199 | $108,196 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $804 | $1,752 | $1,051 | $1,020 |
| Financing Cash Flow | $26,627 | $124,738 | $41,310 | $109,216 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$119,979 | $117,624 | -$15,582 | $47,566 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $240,551 | $122,927 | $138,509 | $90,943 |
| End Cash | $120,572 | $240,551 | $122,927 | $138,509 |
| Free Cash Flow | -$118,120 | -$114,660 | -$58,366 | -$60,912 |